Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3200]

New hybrid 'NOSH aspirin' as possible anti-cancer drug

New hybrid 'NOSH aspirin' as possible anti-cancer drug

FDA approves Incyte's ruxolitinib for patients with myelofibrosis

FDA approves Incyte's ruxolitinib for patients with myelofibrosis

New estimates predict nearly 1.3 million deaths from cancer in the EU in 2012, but the rate of people dying from the disease is declining

New estimates predict nearly 1.3 million deaths from cancer in the EU in 2012, but the rate of people dying from...

Targeted drug helps leukaemia patients who do not benefit from initial therapy

Targeted drug helps leukaemia patients who do not benefit from initial therapy

New microfluidic device used to diagnose and monitor cancer and other diseases

New microfluidic device used to diagnose and monitor cancer and other diseases

Women, young people and ethnic minorities most difficult to diagnose with cancer

Women, young people and ethnic minorities most difficult to diagnose with cancer

FDA bolsters doxorubicin and methotrexate

FDA bolsters doxorubicin and methotrexate

Spatial proximity plays important role in chromosome translocation

Spatial proximity plays important role in chromosome translocation

American Society of Hematology (ASH) statement on critical methotrexate drug shortage

American Society of Hematology (ASH) statement on critical methotrexate drug shortage

Complications of blood cancers make termination advisable at early stages of pregnancy; but cancer therapy is possible for later stage pregnancies

Complications of blood cancers make termination advisable at early stages of pregnancy; but cancer therapy is...

More from ecancer